Marshall Wace’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-430
| Closed | -$14.1K | – | 2337 |
|
|
2023
Q3 | $14.1K | Sell |
430
-23,048
| -98% | -$753K | ﹤0.01% | 1782 |
|
|
2023
Q2 | $1.37M | Buy |
+23,478
| New | +$1.37M | ﹤0.01% | 1280 |
|
|
2022
Q2 | – | Sell |
-437
| Closed | -$23K | – | 3234 |
|
|
2022
Q1 | $23K | Sell |
437
-1,579
| -78% | -$83.1K | ﹤0.01% | 2527 |
|
|
2021
Q4 | $139K | Buy |
2,016
+1,175
| +140% | +$81K | ﹤0.01% | 2600 |
|
|
2021
Q3 | $133K | Buy |
841
+384
| +84% | +$60.7K | ﹤0.01% | 2253 |
|
|
2021
Q2 | $89K | Buy |
+457
| New | +$89K | ﹤0.01% | 2018 |
|